August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.

Seattle, USA-based biotech Curevo Vaccine, which is developing varicella zoster virus (VZV) vaccines with improved tolerability, today announces the closing of a $110 million Series B round to advance ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former ...

Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

目前中国的戊肝疫苗全程需要接种三针，每接种一针戊肝疫苗，都能精准触发人体的免疫应答，催生出强大的抗体力量，并促使其不断进化、成熟，以更好地对抗戊肝病毒的侵袭。这一成果不仅彰显了我国在疫苗研发领域的领先地位，也为全球戊肝防控工作提供了有力支持。

Here is everything you need to know about the recent case of human coronavirus case in Kolkata. Understanding the symptoms of ...

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...